| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J9271 |
Injection, pembrolizumab, 1 mg |
4,313 |
2,882 |
$38.88M |
| J9035 |
Injection, bevacizumab, 10 mg |
5,164 |
2,649 |
$21.35M |
| J9299 |
Injection, nivolumab, 1 mg |
2,026 |
1,286 |
$15.23M |
| J9355 |
Injection, trastuzumab, excludes biosimilar, 10 mg |
2,773 |
1,931 |
$12.34M |
| J9306 |
Injection, pertuzumab, 1 mg |
1,768 |
1,241 |
$9.25M |
| J9312 |
Injection, rituximab, 10 mg |
1,164 |
595 |
$5.54M |
| J0897 |
Injection, denosumab, 1 mg |
1,654 |
1,373 |
$3.74M |
| J9395 |
Injection, fulvestrant, 25 mg |
1,191 |
989 |
$1.97M |
| J9055 |
Injection, cetuximab, 10 mg |
170 |
98 |
$1.10M |
| J9022 |
Injection, atezolizumab, 10 mg |
158 |
103 |
$992K |
| J2506 |
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg |
250 |
168 |
$955K |
| J9310 |
Injection, rituximab, 100 mg |
199 |
85 |
$636K |
| J9070 |
Cyclophosphamide, 100 mg |
1,238 |
730 |
$629K |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
2,588 |
1,315 |
$431K |
| J9358 |
Injection, fam-trastuzumab deruxtecan-nxki, 1 mg |
39 |
24 |
$391K |
| J9171 |
Injection, docetaxel, 1 mg |
1,637 |
852 |
$359K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
3,997 |
2,034 |
$277K |
| J2505 |
Injection, pegfilgrastim, 6 mg |
51 |
36 |
$263K |
| J3489 |
Injection, zoledronic acid, 1 mg |
2,075 |
1,815 |
$183K |
| J1453 |
Injection, fosaprepitant, 1 mg |
1,019 |
699 |
$173K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
206 |
164 |
$172K |
| J9190 |
Injection, fluorouracil, 500 mg |
4,257 |
2,184 |
$162K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
78 |
55 |
$90K |
| J9045 |
Injection, carboplatin, 50 mg |
2,630 |
1,467 |
$87K |
| J9267 |
Injection, paclitaxel, 1 mg |
1,812 |
961 |
$81K |
| J9206 |
Injection, irinotecan, 20 mg |
951 |
494 |
$57K |
| J9000 |
Injection, doxorubicin hydrochloride, 10 mg |
950 |
553 |
$40K |
| J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
17 |
13 |
$39K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
8,924 |
6,715 |
$37K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
11,540 |
8,452 |
$36K |
| J1442 |
Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram |
16 |
13 |
$27K |
| J9202 |
Goserelin acetate implant, per 3.6 mg |
45 |
40 |
$24K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
9,610 |
7,317 |
$14K |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
49 |
46 |
$8K |
| J9060 |
Injection, cisplatin, powder or solution, 10 mg |
189 |
143 |
$8K |
| J7321 |
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose |
16 |
13 |
$7K |
| J7507 |
Tacrolimus, immediate release, oral, 1 mg |
28 |
19 |
$6K |
| S0028 |
Injection, famotidine, 20 mg |
6,170 |
4,746 |
$6K |
| J2780 |
Injection, ranitidine hydrochloride, 25 mg |
141 |
113 |
$3K |
| J3490 |
Unclassified drugs |
1,234 |
829 |
$2K |
| J9370 |
Vincristine sulfate, 1 mg |
17 |
12 |
$152.19 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
42 |
25 |
$134.06 |